Riskpilot← Back to searchSign inGet full accessNØTTERØY FYSIOTERAPI AS
ASActiveOrg 922124728Sjølyst 23, 3120 NøtterøyPhysiotherapy activities · NACE 8695Est. 20190 employees
Revenue 2025
NOK 999K
+20% vs 2024
EBITDA margin
6.4%
-41% vs 2024
Equity ratio
98.1%
Financial strength
Net profit 2025
NOK 54K
+168% vs 2024
| Revenue | NOK 999K | +20% |
| EBITDA | NOK 64K | -41% |
| Net profit | NOK 54K | +168% |
| Total assets | NOK 489K | +10% |
| Equity | NOK 480K | +13% |
| Employees | 0 | — |
Legal name
NØTTERØY FYSIOTERAPI AS
Org number
922124728
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
28. januar 2019
Share capital
NOK 240 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Fysioterapi virksomhet. Utleie av lokaler, investering og finansiering av enhver art, herunder investering og finansiering av fast eiendom samt hva hermed står i forbindelse, herunder delta i andre selskaper med lignende virksomhet.
Address
Sjølyst 23, 3120 Nøtterøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 644 | 785 | 813 | 834 | 999 |
| Staff expenses | −0 | −1 | −8 | −8 | −0 |
| EBITDA | 61 | 50 | 190 | 109 | 64 |
| Depreciation & amort. | −61 | −64 | −78 | −89 | −5 |
| EBIT | 1 | −14 | 112 | 19 | 59 |
| Net financials | 0 | 1 | 4 | 7 | 10 |
| Profit before tax | 1 | −13 | 116 | 26 | 69 |
| Tax | 0 | −3 | 26 | 6 | 15 |
| Net profit | 1 | −10 | 91 | 20 | 54 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 333 | 320 | 441 | 445 | 489 |
| Equity | 326 | 315 | 406 | 426 | 480 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 | 4 | 35 | 19 | 9 |
| Total debt | 8 | 4 | 35 | 19 | 9 |
EBITDA margin
6.4%
This company
15.8%
Market median
-59% vs market
20212025
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
11.2%
This company
18.4%
Market median
+39% vs market
20212025
Net profit margin
5.4%
This company
8.1%
Market median
-33% vs market
20212025
Asset turnover
2.04×
This company
1.12×
Market median
+82% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NØTTERØY FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Monica Strand | Chief Executive Officer | 0 companies |
| Kate Solstad | Chairman | 0 companies |
| Synnøve Bohlin | Board of Directors | 0 companies |
| Kirsty Arbuthnott Røed | Board of Directors | 0 companies |